Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation

Background Early generation drug‐eluting stents (DESs) showed a high grade of coronary endothelial dysfunction that was attributed to lack of stent reendothelialization. Endothelium‐dependent vasomotor response of current DESs and bioresorbable scaffolds (BRSs) remains unknown. This study sought to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Josep Gomez‐Lara, Loreto Oyarzabal, Luis Ortega‐Paz, Salvatore Brugaletta, Rafael Romaguera, Neus Salvatella, Gerard Roura, Fernando Rivero, Lara Fuentes, Fernando Alfonso, Imanol Otaegui, Bert Vandeloo, Beatriz Vaquerizo, Manel Sabate, Josep Comin‐Colet, Joan‐Antoni Gomez‐Hospital
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/e7913cce93b346ffba45f598dfc9d1cb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e7913cce93b346ffba45f598dfc9d1cb
record_format dspace
spelling oai:doaj.org-article:e7913cce93b346ffba45f598dfc9d1cb2021-11-16T10:22:43ZCoronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation10.1161/JAHA.121.0221232047-9980https://doaj.org/article/e7913cce93b346ffba45f598dfc9d1cb2021-11-01T00:00:00Zhttps://www.ahajournals.org/doi/10.1161/JAHA.121.022123https://doaj.org/toc/2047-9980Background Early generation drug‐eluting stents (DESs) showed a high grade of coronary endothelial dysfunction that was attributed to lack of stent reendothelialization. Endothelium‐dependent vasomotor response of current DESs and bioresorbable scaffolds (BRSs) remains unknown. This study sought to assess the device‐related endothelial function of current devices and to correlate neointima healing with endothelial function. Methods and Results A total of 206 patients from 4 randomized trials treated with the durable‐polymer everolimus‐eluting Xience (n=44), bioresorbable‐polymer sirolimus‐eluting Orsiro (n=35), polymer‐free biolimus‐eluting Biofreedom (n=24), bioactive endothelial‐progenitor cell‐capturing sirolimus‐eluting Combo DES (n=25), polymer‐based everolimus‐eluting Absorb (n=44), and Mg‐based sirolimus‐eluting Magmaris BRS (n=34) underwent endothelium‐dependent vasomotor tests and optical coherence tomography imaging, as per protocol, at follow‐up. Crude vasomotor responses of distal segments to low‐dose acetylcholine (10−6 mol/L) were different between groups: bioresorbablepolymer DEShad the worst (−8.4%±12.6%) and durable‐polymer DES had the most physiologic (−0.4%±11.8%; P=0.014). High‐dose acetylcholine (10−4 mol/L) showed similar responses between groups (ranging from −10.8%±11.6% to −18.1%±15.4%; P=0.229). Device healing was different between devices. Uncovered struts ranged from 6.3%±7.1% (bioresorbable‐polymer DES) to 2.5%±4.5% (bioactive DES; P=0.056). In multivariate models, endothelium‐dependent vasomotor response was associated with age, bioresorbable‐polymer DES, and angiographic lumen loss, but not with strut coverage nor plaque type. Endothelial dysfunction (defined as ≥4% vasoconstriction) was observed in 46.6% of patients with low‐dose and 68.9% with high‐dose acetylcholine, without differences between groups. Conclusions At follow‐up, endothelial dysfunction was frequently observed in distal segments treated with current stents without remarkable differences between devices. Although neointima healing was different between devices, poor healing was not associated with endothelial dysfunction.Josep Gomez‐LaraLoreto OyarzabalLuis Ortega‐PazSalvatore BrugalettaRafael RomagueraNeus SalvatellaGerard RouraFernando RiveroLara FuentesFernando AlfonsoImanol OtaeguiBert VandelooBeatriz VaquerizoManel SabateJosep Comin‐ColetJoan‐Antoni Gomez‐HospitalWileyarticledrug‐eluting stentsendothelial dysfunctionoptical coherence tomographyST‐segment–elevation myocardial infarctionDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
institution DOAJ
collection DOAJ
language EN
topic drug‐eluting stents
endothelial dysfunction
optical coherence tomography
ST‐segment–elevation myocardial infarction
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle drug‐eluting stents
endothelial dysfunction
optical coherence tomography
ST‐segment–elevation myocardial infarction
Diseases of the circulatory (Cardiovascular) system
RC666-701
Josep Gomez‐Lara
Loreto Oyarzabal
Luis Ortega‐Paz
Salvatore Brugaletta
Rafael Romaguera
Neus Salvatella
Gerard Roura
Fernando Rivero
Lara Fuentes
Fernando Alfonso
Imanol Otaegui
Bert Vandeloo
Beatriz Vaquerizo
Manel Sabate
Josep Comin‐Colet
Joan‐Antoni Gomez‐Hospital
Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
description Background Early generation drug‐eluting stents (DESs) showed a high grade of coronary endothelial dysfunction that was attributed to lack of stent reendothelialization. Endothelium‐dependent vasomotor response of current DESs and bioresorbable scaffolds (BRSs) remains unknown. This study sought to assess the device‐related endothelial function of current devices and to correlate neointima healing with endothelial function. Methods and Results A total of 206 patients from 4 randomized trials treated with the durable‐polymer everolimus‐eluting Xience (n=44), bioresorbable‐polymer sirolimus‐eluting Orsiro (n=35), polymer‐free biolimus‐eluting Biofreedom (n=24), bioactive endothelial‐progenitor cell‐capturing sirolimus‐eluting Combo DES (n=25), polymer‐based everolimus‐eluting Absorb (n=44), and Mg‐based sirolimus‐eluting Magmaris BRS (n=34) underwent endothelium‐dependent vasomotor tests and optical coherence tomography imaging, as per protocol, at follow‐up. Crude vasomotor responses of distal segments to low‐dose acetylcholine (10−6 mol/L) were different between groups: bioresorbablepolymer DEShad the worst (−8.4%±12.6%) and durable‐polymer DES had the most physiologic (−0.4%±11.8%; P=0.014). High‐dose acetylcholine (10−4 mol/L) showed similar responses between groups (ranging from −10.8%±11.6% to −18.1%±15.4%; P=0.229). Device healing was different between devices. Uncovered struts ranged from 6.3%±7.1% (bioresorbable‐polymer DES) to 2.5%±4.5% (bioactive DES; P=0.056). In multivariate models, endothelium‐dependent vasomotor response was associated with age, bioresorbable‐polymer DES, and angiographic lumen loss, but not with strut coverage nor plaque type. Endothelial dysfunction (defined as ≥4% vasoconstriction) was observed in 46.6% of patients with low‐dose and 68.9% with high‐dose acetylcholine, without differences between groups. Conclusions At follow‐up, endothelial dysfunction was frequently observed in distal segments treated with current stents without remarkable differences between devices. Although neointima healing was different between devices, poor healing was not associated with endothelial dysfunction.
format article
author Josep Gomez‐Lara
Loreto Oyarzabal
Luis Ortega‐Paz
Salvatore Brugaletta
Rafael Romaguera
Neus Salvatella
Gerard Roura
Fernando Rivero
Lara Fuentes
Fernando Alfonso
Imanol Otaegui
Bert Vandeloo
Beatriz Vaquerizo
Manel Sabate
Josep Comin‐Colet
Joan‐Antoni Gomez‐Hospital
author_facet Josep Gomez‐Lara
Loreto Oyarzabal
Luis Ortega‐Paz
Salvatore Brugaletta
Rafael Romaguera
Neus Salvatella
Gerard Roura
Fernando Rivero
Lara Fuentes
Fernando Alfonso
Imanol Otaegui
Bert Vandeloo
Beatriz Vaquerizo
Manel Sabate
Josep Comin‐Colet
Joan‐Antoni Gomez‐Hospital
author_sort Josep Gomez‐Lara
title Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
title_short Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
title_full Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
title_fullStr Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
title_full_unstemmed Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
title_sort coronary endothelium‐dependent vasomotor function after drug‐eluting stent and bioresorbable scaffold implantation
publisher Wiley
publishDate 2021
url https://doaj.org/article/e7913cce93b346ffba45f598dfc9d1cb
work_keys_str_mv AT josepgomezlara coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT loretooyarzabal coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT luisortegapaz coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT salvatorebrugaletta coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT rafaelromaguera coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT neussalvatella coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT gerardroura coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT fernandorivero coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT larafuentes coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT fernandoalfonso coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT imanolotaegui coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT bertvandeloo coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT beatrizvaquerizo coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT manelsabate coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT josepcomincolet coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
AT joanantonigomezhospital coronaryendotheliumdependentvasomotorfunctionafterdrugelutingstentandbioresorbablescaffoldimplantation
_version_ 1718426578552094720